ADGRA3 and colorectal cancer: Overexpression of GPR125 has also been reported after brain injury and myeloid sarcoma formation, while its downregulation during colorectal cancer is a predictive biomarker of poor prognosis and higher probability of recurrence [13, 29, 38].